This is a firm-fixed-price purchase order contract awarded by the National Institute on Aging (NIA), a civilian agency, to Alamar Biosciences, Inc. for the ALAMAR NULISASEQ INFLAMMATION PANEL 250 REAGENTS. The contract has a ceiling value of $324,000.00 and a period of performance through July 7, 2025. Alamar Biosciences, Inc. is a for-profit manufacturer of specialized biomedical research tools and services, with a focus on diagnostic technologies for central nervous system disorders like Alzheimer's disease. The contract does not have a set-aside designation. The key deliverables include a single-plex NULISAseq assay for HDGFL2 in plasma samples, proteomic analysis of plasma samples, laboratory testing services, and the provision of the ARGO HT Instrument. This contract builds on Alamar Biosciences' prior experience providing advanced biomedical research support services to the NIA.
Generated 4/4/25, 10:04 AM